Modified plastic compression of collagen hydrogels provides an ideal matrix for clinically applicable skin substitutes.
Braziulis E, Diezi M, Biedermann T, Pontiggia L, Schmucki M, Hartmann-Fritsch F, Luginbühl J, Schiestl C, Meuli M, Reichmann E.
Tissue Eng Part C Methods. 2011 Dec 25. (Epub ahead of print)

Matriderm(®) 1 mm versus Integra(®) Single Layer 1.3 mm for one-step closure of full thickness skin defects: a comparative experimental study in rats.
Böttcher-Haberzeth S, Biedermann T, Schiestl C, Hartmann-Fritsch F, Schneider J, Reichmann E, Meuli M.
Pediatr Surg Int. 2012 Feb; 28 (2): 171-7

Engineering Melanoma Progression in a Humanized Environment In Vivo.
Kiowski G, Biedermann T, Widmer DS, Civenni G, Burger C, Dummer R, Sommer L, Reichmann E.
Journal of Investigative Dermatology 2012 Jan; 132(1):144-153

Osmotic expanders in children: No filling - no control - no problem?
Böttcher-Haberzeth S, Kapoor S, Meuli M, Neuhaus K, Biedermann T, Reichmann E, Schiestl C.
Eur J Pediatr Surg. 2011 May;21(3):163-7.

Skingineering I: engineering porcine dermo-epidermal skin analogues for autologous transplantation in a large animal model.
Braziulis E, Biedermann T, Hartmann-Fritsch F, Schiestl C, Pontiggia L, Böttcher-Haberzeth S, Reichmann E, Meuli M.
Pediatr Surg Int. 2011 Mar;27(3):241-7.

Determining the origin of cells in tissue engineered skin substitutes: a pilot study employing in situ hybridization.
Weber AD, Pontiggia L, Biedermann T, Schiestl C, Meuli M, Reichmann E.
Pediatr Surg Int. 2011 Mar;27(3):255-61.

Skingineering II: transplantation of large-scale laboratory-grown skin analogues in a new pig model.
Schiestl C, Biedermann T, Braziulis E, Hartmann-Fritsch F, Böttcher-Haberzeth S, Arras M, Cesarovic N, Nicolls F, Linti C, Reichmann E, Meuli M.
Pediatr Surg Int. 2011 Mar;27(3):249-54.

Human eccrine sweat gland cells can reconstitute a stratified epidermis.
Biedermann T, Pontiggia L, Böttcher-Haberzeth S, Tharakan S, Braziulis E, Schiestl C, Meuli M, Reichmann E.
J Invest Dermatol. 2010; 130: 1996–2009. doi:10.1038/jid.2010.83

Markers to evaluate the quality and self-renewing potential of engineered human skin substitutes in vitro and after transplantation.
Pontiggia L, Biedermann T, Meuli M, Widmer D, Böttcher-Haberzeth S, Schiestl C, Schneider J, Braziulis E, Montaño I, Meuli-Simmen C, Reichmann E.
J Invest Dermatol. 2009; 129: 480-490.

Matriderm® versus Integra®: A comparative experimental study. 
Schneider J, Biedermann T, Widmer D, Montaño I, Meuli M, Reichmann E, Schiestl C. 
Burns. 2009; 35: 51-57.

Formation of human capillaries in vitro: The engineering of pre-vascularized matrices.
Montano I, Schiestl C, Schneider J, Pontiggia L, Luginbühl J, Biedermann T, Böttcher-Haberzeth S, Braziulis E, Meuli M, Reichmann E.
Tissue Engineering Part A. 2010 Jan; 16 (1): 269-282.

Transglutaminases, involucrin, and loricrin as markers of epidermal differentiation in skin substitutes derived from human sweat gland cells.
Tharakan S, Pontiggia L, Biedermann T, Böttcher-Haberzeth S, Schiestl C, Reichmann E, Meuli M. 
Pediatr Surg Int. 2010 Jan; 26 (1): 71-77.

Tissue engineering of skin.
Böttcher-Haberzeth S, Biedermann T, Reichmann E.
Burns. 2010; 36 (4): 450-460.

Wege zu einer neuen Haut: Von den zellbiologischen Grundlagen über Tissue Engineering zu einem neuen Hautsubstitut.
Böttcher-Haberzeth S, Biedermann T, Reichmann E.
Paediatrica. 2009; 20 (4): 57-61.